Mesoblast Limited (MESO)
(Delayed Data from NSDQ)
$6.24 USD
+0.09 (1.46%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $6.29 +0.05 (0.80%) 7:58 PM ET
4-Sell of 5 4
F Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for Mesoblast Limited falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 8 | 10 | 7 | 32 | 17 |
Cost Of Goods | 25 | 31 | 33 | 25 | 15 |
Gross Profit | -18 | -21 | -25 | 7 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 44 | 54 | 64 | 81 | 89 |
Income After Depreciation & Amortization | -62 | -74 | -89 | -74 | -87 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 20 | 17 | 11 | 13 | 11 |
Pretax Income | -82 | -92 | -100 | -87 | -99 |
Income Taxes | 0 | 0 | -1 | -9 | -9 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -82 | -91 | -99 | -78 | -90 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -82 | -91 | -99 | -78 | -90 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -58 | -70 | -85 | -70 | -85 |
Depreciation & Amortization (Cash Flow) | 4 | 4 | 4 | 4 | 2 |
Income After Depreciation & Amortization | -62 | -74 | -89 | -74 | -87 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 73.91 | 64.88 | 60.51 | 52.88 | 49.45 |
Diluted EPS Before Non-Recurring Items | -1.10 | -1.40 | -1.64 | -1.48 | -1.82 |
Diluted Net EPS (GAAP) | -1.11 | -1.41 | -1.63 | -1.47 | -1.82 |
Fiscal Year end for Mesoblast Limited falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 1.93 | 1.94 |
Cost Of Goods | NA | NA | NA | 6.37 | 6.25 |
Gross Profit | NA | NA | NA | -4.44 | -4.31 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 13.07 | 9.36 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | -17.51 | -13.67 |
Non-Operating Income | NA | NA | NA | 0.00 | 0.00 |
Interest Expense | NA | NA | NA | 4.45 | 4.98 |
Pretax Income | NA | NA | NA | -21.96 | -18.65 |
Income Taxes | NA | NA | NA | -0.04 | -0.05 |
Minority Interest | NA | NA | NA | 0.00 | 0.00 |
Investment Gains/Losses | NA | NA | NA | 0.00 | 0.00 |
Other Income/Charges | NA | NA | NA | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | NA | -21.92 | -18.60 |
Extras & Discontinued Operations | NA | NA | NA | 0.00 | 0.00 |
Net Income (GAAP) | NA | NA | NA | -21.92 | -18.60 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 78.56 | 73.52 |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | -0.28 | -0.26 |
Diluted Net EPS (GAAP) | NA | NA | NA | -0.28 | -0.25 |